Address
Email address
Phone number
Website
Endokrinoloog. Tallinna Endokrinoloogia Kliiniku vastuvõtud toimuvad Tartu mnt 16,3.korrus, Tallinnas ja Metsa 28, Mai apteegi majas, Pärnus. Endokrinoloogi,diabeedi- ja jalaõe vastuvõtud. Registreeri vastuvõtule tel 5566 5451 või 5566 5135 või kasuta digiregistratuuri www.endokrinoloog.ee/digiregistratuur.
Name
Reveron Baltic OÜ
Registry code
11527271
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.08.2008 (16)
Financial year
01.01-31.12
Capital
111 000.00 €
Activity
86221 - Provision of specialised medical treatment
481 240 €
315 916 €
66%
1 076 €
(estimate is approximate)
1 014 354 €
1
Submitted
No tax arrears
31%
26%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Verner Fogel 06.01.1977 (47) | 100% - 111 000.00 EUR | Board member | Direct ownership | Founder |
Margit Okas 22.02.1974 (50) | - | Procurator | - | |
Riina Vello 21.02.1968 (56) | - | - | - | Founder |
2019 26.08.2020 | 2020 31.05.2021 | 2021 29.03.2022 | 2022 23.03.2023 | 2023 03.04.2024 | |
---|---|---|---|---|---|
Total Revenue | 433 691 € | 419 237 € | 405 930 € | 386 336 € | 481 240 € |
Net profit (loss) for the period | 165 564 € | 142 423 € | 282 452 € | -664 € | 315 916 € |
Profit Margin | 38% | 34% | 70% | -0% | 66% |
Current Assets | 277 771 € | 466 619 € | 801 259 € | 668 841 € | 817 284 € |
Fixed Assets | 276 049 € | 263 169 € | 257 346 € | 351 746 € | 378 316 € |
Total Assets | 553 820 € | 729 788 € | 1 058 605 € | 1 020 587 € | 1 195 600 € |
Current Liabilities | 81 623 € | 215 660 € | 127 952 € | 242 178 € | 181 246 € |
Non Current Liabilities | 87 167 € | 0 € | 143 335 € | 29 970 € | 0 € |
Total Liabilities | 168 790 € | - | 271 287 € | 272 148 € | - |
Share Capital | - | - | - | - | - |
Equity | 385 030 € | 514 128 € | 787 318 € | 748 439 € | 1 014 354 € |
Employees | 0 | 0 | 1 | 1 | 1 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 7 059.86 € | 3 625.41 € | 1 |
2023 Q4 | - | 5 476.54 € | 3 285.98 € | 1 |
2023 Q3 | - | 3 926.73 € | 2 245.62 € | 1 |
2023 Q2 | - | 3 102.12 € | 3 148.12 € | 1 |
2023 Q1 | - | 5 697.47 € | 3 348.18 € | 1 |
2022 Q4 | - | 5 288.4 € | 2 255.89 € | 1 |
2022 Q3 | - | 2 840.19 € | 2 978.23 € | 1 |
2022 Q2 | - | 2 831.59 € | 3 816.96 € | 1 |
2022 Q1 | - | 3 772.52 € | 2 716.05 € | 1 |
2021 Q4 | - | 3 197.45 € | 1 829.98 € | 1 |
2021 Q3 | - | 535.58 € | 535.58 € | 1 |
2021 Q2 | - | 590.33 € | 590.33 € | - |
2021 Q1 | - | 1 989.33 € | 442.74 € | - |
2020 Q4 | - | 442.74 € | 442.74 € | - |
2020 Q3 | - | 1 760.94 € | 610.29 € | - |
2020 Q2 | - | 737.92 € | 737.92 € | - |
2020 Q1 | - | 1 647.09 € | 329.58 € | - |